Patricia Gayle Belanger, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 34 Twin Mountain Rd, Whitefield, NH 03598 Phone: 603-837-3088 |
Lisa Bourassa, Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 34 Twin Mountain Rd, Whitefield, NH 03598 Phone: 603-837-3088 Fax: 603-837-9161 |
News Archive
Senate Democrats on Tuesday "scaled down" their version of the war supplemental appropriations bill but retained a provision that would block for one year seven new Medicaid regulations proposed by the Bush administration, CQ Today reports.
Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs, announced today that it has initiated a phase 1 clinical trial to assess the safety, tolerability and pharmacokinetic profile of AVL-292, a novel, orally available, covalent drug that targets Bruton's tyrosine kinase (Btk). AVL-292 is the first product candidate to enter clinical evaluation from Avila's proprietary covalent drug platform, Avilomics™.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that it has entered into an agreement with Ablynx, to co-discover and co-develop Nanobodies against two targets in oncology and immunology. The agreement includes an upfront cash payment to Ablynx of EUR10 million.
The DECIDE study shows that 4-weekly daclizumab high-yield process reduces disease activity in patients with relapsing–remitting multiple sclerosis more effectively than weekly interferon beta-1a, albeit at the cost of more adverse effects.
› Verified 7 days ago